Clinical characteristics of patients with resistant hypertension: the RESIST-POL study

E. Florczak, A. Prejbisz, E. Szwench-Pietrasz, P. Śliwiński, P. Bieleń, A. Klisiewicz, I. Michałowska, E. Warchoł, M. Januszewicz, M. Kała, A. Witkowski, A. Wiȩcek, K. Narkiewicz, Virend Somers, A. Januszewicz

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Recent studies indicate that resistant hypertension (RHTN) is present in about 12% of the treated hypertensive population. However, patients with true RHTN (confirmed out of the office) have not been widely studied. We prospectively studied 204 patients (123 male, 81female, mean age 48.4 years, range 19-65 years) with truly RHTN (ambulatory daytime mean blood pressure >135/85 mm Hg). We evaluated the frequency of obstructive sleep apnea (OSA), renal artery stenosis (RAS), primary aldosteronism (PA) and other secondary forms of hypertension (HTN) and conditions. Mild, moderate and severe OSA were present in 55 (27.0%), 38 (18.6%) and 54 (26.5%) patients, respectively. Secondary forms of HTN were diagnosed in 49 patients (24.0%), the most frequent being PA (15.7%) and RAS (5.4%). Metabolic syndrome (MS) was present in 65.7% of patients. Excessive sodium excretion was evident in 33.3% of patients and depression in 36.8% patients. In patients with RHTN, OSA and MS were the most frequent conditions, frequently overlapping with each other and also with PA. Our data indicate that in the vast majority of patients with truly RHTN, at least one of three co-morbidities - OSA, MS and PA - is present. Other conditions, even though less frequent, should also be taken into the consideration.

Original languageEnglish (US)
Pages (from-to)678-685
Number of pages8
JournalJournal of Human Hypertension
Volume27
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Hypertension
Hyperaldosteronism
Obstructive Sleep Apnea
Renal Artery Obstruction
Sodium
Blood Pressure
Morbidity
Population

Keywords

  • metabolic syndrome
  • obstructive sleep apnea
  • primary aldosteronism
  • renal artery stenosis
  • resistant hypertension

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Florczak, E., Prejbisz, A., Szwench-Pietrasz, E., Śliwiński, P., Bieleń, P., Klisiewicz, A., ... Januszewicz, A. (2013). Clinical characteristics of patients with resistant hypertension: the RESIST-POL study. Journal of Human Hypertension, 27(11), 678-685. https://doi.org/10.1038/jhh.2013.32

Clinical characteristics of patients with resistant hypertension : the RESIST-POL study. / Florczak, E.; Prejbisz, A.; Szwench-Pietrasz, E.; Śliwiński, P.; Bieleń, P.; Klisiewicz, A.; Michałowska, I.; Warchoł, E.; Januszewicz, M.; Kała, M.; Witkowski, A.; Wiȩcek, A.; Narkiewicz, K.; Somers, Virend; Januszewicz, A.

In: Journal of Human Hypertension, Vol. 27, No. 11, 11.2013, p. 678-685.

Research output: Contribution to journalArticle

Florczak, E, Prejbisz, A, Szwench-Pietrasz, E, Śliwiński, P, Bieleń, P, Klisiewicz, A, Michałowska, I, Warchoł, E, Januszewicz, M, Kała, M, Witkowski, A, Wiȩcek, A, Narkiewicz, K, Somers, V & Januszewicz, A 2013, 'Clinical characteristics of patients with resistant hypertension: the RESIST-POL study', Journal of Human Hypertension, vol. 27, no. 11, pp. 678-685. https://doi.org/10.1038/jhh.2013.32
Florczak E, Prejbisz A, Szwench-Pietrasz E, Śliwiński P, Bieleń P, Klisiewicz A et al. Clinical characteristics of patients with resistant hypertension: the RESIST-POL study. Journal of Human Hypertension. 2013 Nov;27(11):678-685. https://doi.org/10.1038/jhh.2013.32
Florczak, E. ; Prejbisz, A. ; Szwench-Pietrasz, E. ; Śliwiński, P. ; Bieleń, P. ; Klisiewicz, A. ; Michałowska, I. ; Warchoł, E. ; Januszewicz, M. ; Kała, M. ; Witkowski, A. ; Wiȩcek, A. ; Narkiewicz, K. ; Somers, Virend ; Januszewicz, A. / Clinical characteristics of patients with resistant hypertension : the RESIST-POL study. In: Journal of Human Hypertension. 2013 ; Vol. 27, No. 11. pp. 678-685.
@article{9cacba35509746da8edbc387b2edb5c3,
title = "Clinical characteristics of patients with resistant hypertension: the RESIST-POL study",
abstract = "Recent studies indicate that resistant hypertension (RHTN) is present in about 12{\%} of the treated hypertensive population. However, patients with true RHTN (confirmed out of the office) have not been widely studied. We prospectively studied 204 patients (123 male, 81female, mean age 48.4 years, range 19-65 years) with truly RHTN (ambulatory daytime mean blood pressure >135/85 mm Hg). We evaluated the frequency of obstructive sleep apnea (OSA), renal artery stenosis (RAS), primary aldosteronism (PA) and other secondary forms of hypertension (HTN) and conditions. Mild, moderate and severe OSA were present in 55 (27.0{\%}), 38 (18.6{\%}) and 54 (26.5{\%}) patients, respectively. Secondary forms of HTN were diagnosed in 49 patients (24.0{\%}), the most frequent being PA (15.7{\%}) and RAS (5.4{\%}). Metabolic syndrome (MS) was present in 65.7{\%} of patients. Excessive sodium excretion was evident in 33.3{\%} of patients and depression in 36.8{\%} patients. In patients with RHTN, OSA and MS were the most frequent conditions, frequently overlapping with each other and also with PA. Our data indicate that in the vast majority of patients with truly RHTN, at least one of three co-morbidities - OSA, MS and PA - is present. Other conditions, even though less frequent, should also be taken into the consideration.",
keywords = "metabolic syndrome, obstructive sleep apnea, primary aldosteronism, renal artery stenosis, resistant hypertension",
author = "E. Florczak and A. Prejbisz and E. Szwench-Pietrasz and P. Śliwiński and P. Bieleń and A. Klisiewicz and I. Michałowska and E. Warchoł and M. Januszewicz and M. Kała and A. Witkowski and A. Wiȩcek and K. Narkiewicz and Virend Somers and A. Januszewicz",
year = "2013",
month = "11",
doi = "10.1038/jhh.2013.32",
language = "English (US)",
volume = "27",
pages = "678--685",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Clinical characteristics of patients with resistant hypertension

T2 - the RESIST-POL study

AU - Florczak, E.

AU - Prejbisz, A.

AU - Szwench-Pietrasz, E.

AU - Śliwiński, P.

AU - Bieleń, P.

AU - Klisiewicz, A.

AU - Michałowska, I.

AU - Warchoł, E.

AU - Januszewicz, M.

AU - Kała, M.

AU - Witkowski, A.

AU - Wiȩcek, A.

AU - Narkiewicz, K.

AU - Somers, Virend

AU - Januszewicz, A.

PY - 2013/11

Y1 - 2013/11

N2 - Recent studies indicate that resistant hypertension (RHTN) is present in about 12% of the treated hypertensive population. However, patients with true RHTN (confirmed out of the office) have not been widely studied. We prospectively studied 204 patients (123 male, 81female, mean age 48.4 years, range 19-65 years) with truly RHTN (ambulatory daytime mean blood pressure >135/85 mm Hg). We evaluated the frequency of obstructive sleep apnea (OSA), renal artery stenosis (RAS), primary aldosteronism (PA) and other secondary forms of hypertension (HTN) and conditions. Mild, moderate and severe OSA were present in 55 (27.0%), 38 (18.6%) and 54 (26.5%) patients, respectively. Secondary forms of HTN were diagnosed in 49 patients (24.0%), the most frequent being PA (15.7%) and RAS (5.4%). Metabolic syndrome (MS) was present in 65.7% of patients. Excessive sodium excretion was evident in 33.3% of patients and depression in 36.8% patients. In patients with RHTN, OSA and MS were the most frequent conditions, frequently overlapping with each other and also with PA. Our data indicate that in the vast majority of patients with truly RHTN, at least one of three co-morbidities - OSA, MS and PA - is present. Other conditions, even though less frequent, should also be taken into the consideration.

AB - Recent studies indicate that resistant hypertension (RHTN) is present in about 12% of the treated hypertensive population. However, patients with true RHTN (confirmed out of the office) have not been widely studied. We prospectively studied 204 patients (123 male, 81female, mean age 48.4 years, range 19-65 years) with truly RHTN (ambulatory daytime mean blood pressure >135/85 mm Hg). We evaluated the frequency of obstructive sleep apnea (OSA), renal artery stenosis (RAS), primary aldosteronism (PA) and other secondary forms of hypertension (HTN) and conditions. Mild, moderate and severe OSA were present in 55 (27.0%), 38 (18.6%) and 54 (26.5%) patients, respectively. Secondary forms of HTN were diagnosed in 49 patients (24.0%), the most frequent being PA (15.7%) and RAS (5.4%). Metabolic syndrome (MS) was present in 65.7% of patients. Excessive sodium excretion was evident in 33.3% of patients and depression in 36.8% patients. In patients with RHTN, OSA and MS were the most frequent conditions, frequently overlapping with each other and also with PA. Our data indicate that in the vast majority of patients with truly RHTN, at least one of three co-morbidities - OSA, MS and PA - is present. Other conditions, even though less frequent, should also be taken into the consideration.

KW - metabolic syndrome

KW - obstructive sleep apnea

KW - primary aldosteronism

KW - renal artery stenosis

KW - resistant hypertension

UR - http://www.scopus.com/inward/record.url?scp=84885589246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885589246&partnerID=8YFLogxK

U2 - 10.1038/jhh.2013.32

DO - 10.1038/jhh.2013.32

M3 - Article

C2 - 23698004

AN - SCOPUS:84885589246

VL - 27

SP - 678

EP - 685

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - 11

ER -